On the evening of October 10,Xi'an Kangtuo Medical Technology Co., Ltd. disclosed that the company recently obtained a Class III "Medical Device Registration Certificate" issued by the National Medical Products Administration. The product, named abutments and accessories, is used for connecting, supporting, and retaining prostheses or the suprastructure of implants.。
Xi'an Kangtuo Medical Technology Co., Ltd. stated that the product is part of its ongoing R&D project titled “Development of High-End Osseointegrated Implants and Accessories.” Manufactured from commercially pure titanium (TA4G) and titanium alloy (TC4) compliant with the GB/T 13810 standard, the product features star-shaped and octagonal connection interfaces. The design ensures consistency in the connection structure and provides anti-rotation capabilities, thereby enhancing product compatibility and enabling more convenient operation.
It is reported that the approval of this product will further enrich the company’s dental product portfolio and accelerate the overall market launch of its next-generation tapered implants and immediate implantation system series.
Revenue Exceeds 40 Million Yuan, with Strong Growth in Dental Business
Xi'an Kangtuo Medical Technology Co., Ltd. has demonstrated strong momentum in the field of dental medical devices, according to the company's official website, in 2023, its oral care products, absorbable cranial repair and maxillofacial reconstruction products, and associated surgical instruments collectively achieved significant revenue growth, representing a 36.25% year-over-year increase compared to the same period in 2022.。
The continuous improvement of Kangtuo Medical’s oral care product line and the enhancement of its brand awareness are key factors contributing to its outstanding performance. Centered on the goal of providing “integrated dental synergy solutions,” the company has implemented a comprehensive product portfolio that covers dental implants, surgical guides, titanium meshes, GBR series pins, dental instrument kits, and related surgical auxiliary devices.
Notably, the surgical guide features a precise and ingenious design that provides accurate guidance for implant surgery, significantly enhancing both procedural efficiency and safety. Titanium meshes and GBR series pins play a pivotal role in alveolar bone repair and bone augmentation, offering robust support for prosthodontic rehabilitation. Furthermore, the inclusion of dental instrument kits and related surgical accessories further optimizes the entire treatment workflow, providing dental professionals with convenient and efficient operational tools.
Furthermore, Xi'an Kangtuo Medical Technology Co., Ltd. spares no effort in research and development innovation.The company’s next-generation “high-end osseointegrated dental implants and accessories,” currently under development, will achieve new breakthroughs in materials and surface treatment technologies, enhancing osseointegration with bone tissue to ensure implant stability and long-term success rates.In the field of regenerative materials, Kangtuo Medical also holds a stake in Rongyuan Biology, jointly conducting product research and development on oral absorbable biological membranes and oral bone repair materials in the field of dental implants.
To reshape the brand influence of its oral care business, Kangtuo Medical has also launched a comprehensive dental solution under the “Yizhi” brand. This solution comprises dental implants, Yizhi surgical guides, Kangtuo titanium meshes, BioMesh dental series toolkits, Kangtuo GBR series tacks, and a dental academic platform, providing more comprehensive and professional services to dental professionals and patients.
Upstream raw material markets remain dominated by foreign enterprises
From the perspective of the entire dental medical device ecosystem, the upstream sector primarily consists of raw materials, including restorative and filling materials, denture fabrication materials, orthodontic materials, as well as other metals and components. The midstream sector is dominated by the manufacturing of dental medical devices, specifically encompassing dental examination equipment and instruments, dental treatment equipment and instruments, and dentures. The downstream sector comprises service-oriented institutions such as hospitals and dental clinics. The end consumers of dental medical devices are primarily dental patients and individuals seeking dental care services; demand varies across these groups due to differences in income levels and health awareness.
In terms of upstream raw materials for dental medical devices, China offers a wide variety of products; however, the market remains dominated by European and American brands, with a low rate of domestic substitution. Key foreign players include Dentsply Sirona, Bego, Dentaurum, Degudent, and ARGEN.Among them, Dentsply Sirona’s synthetic dental materials include Ceram.x Spectra® ST and Gingiva Composites.
The former is a synthetic flowable dental material specifically designed for anterior and posterior restorations. It achieves a balance among handling properties, viscosity, and shade, offering five universal CLOUD™ shades that cover the entire VITA®1 range to ensure optimal handling. Additionally, it provides extra opaque dentin and translucent enamel shades to simplify the shade-matching process.
The latter is a light-cured veneer composite material used to fabricate temporary restorations, thereby immediately achieving the aesthetic appearance of the final restoration. It is resistant to chipping, ensures aesthetic outcomes, and is easy to apply.
Meanwhile, domestic enterprises such as Aidite and Sinocera are also pursuing innovative development.Aierchuang’s “Cibeijian” brand is crafted from high-translucency zirconia and lithium disilicate glass-ceramic materials, offering excellent hardness, strength, translucency, and anti-aging properties.This material not only effectively prevents food impaction and reduces the incidence of dental caries, but also provides an appearance and function similar to natural teeth. With independent research, development, and innovation by domestic enterprises, high-performance raw materials for oral medical devices with independent intellectual property rights will be launched in the future, benefiting more patients.